Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Discusses Frequency of NHI Drug Price Revisions
July 24, 2006
- SEMINAR
July 24, 2006
- Basic Policies 2006 Call For Enhancement of Drug Industry's Int'l Competitiveness
July 24, 2006
- SELF-MEDICATION NEWS IN BRIEF
July 24, 2006
- NEW PRODUCTS
July 24, 2006
- NEW PRODUCTS
July 24, 2006
- GENERIC NEWS IN BRIEF
July 24, 2006
- Drug Development Beyond Boundaries - Today's Global Cooperative Clinical Trials -
July 24, 2006
- Kotobuki Pharm. Improved Business by Outsourcing Distribution
July 24, 2006
- R&D NEWS IN BRIEF
July 24, 2006
- Meiji Seika Aims for \10 Bil. in Generic Drug Sales in FY2008
July 24, 2006
- Efficacy of Anti-obesity Drug Confirmed in PII: Shionogi
July 24, 2006
- Nichi-iko Strengthening Customer Relations, Distribution System
July 24, 2006
- MEDICAL DEVICE NEWS IN BRIEF
July 24, 2006
- Sandoz K.K. Aims for Sharp Increase in Sales by 2010
July 24, 2006
- NEW PRODUCTS
July 24, 2006
- Alfresa HD to Focus on Low-cost Operations: Mr Watanabe
July 17, 2006
- Astellas Pharma's R&D to Focus on 3 Promising Products
July 17, 2006
- NHO Slims Its Formulary, Retains Amlodin, Eliminates Norvasc
July 17, 2006
- TeGenero Files for Bankruptcy
July 17, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…